pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
VONJO
VONJO (PACRITINIB CITRATE)
Sobi Inc
0 catalysts
VOQUEZNA
VOQUEZNA (VONOPRAZAN FUMARATE)
1 INDICATIONS AND USAGE VOQUEZNA TRIPLE PAK, is a co-packaged product contain…
Potassium-transporting ATPase
$PHATPhathom Pharmaceuticals, Inc.
0 catalysts
VOQUEZNA DUAL PAK
VOQUEZNA DUAL PAK (AMOXICILLIN)
1 INDICATIONS AND USAGE VOQUEZNA TRIPLE PAK, is a co-packaged product contain…
Bacterial penicillin-binding protein
$PHATPhathom Pharmaceuticals, Inc.
0 catalysts
← prev
page 173 of 271
next →
131
Pain89
Neurology1
VOQUEZNA TRIPLE PAK
VOQUEZNA TRIPLE PAK (AMOXICILLIN)
1 INDICATIONS AND USAGE VOQUEZNA TRIPLE PAK, is a co-packaged product contain…
Bacterial penicillin-binding protein
$PHATPhathom Pharmaceuticals, Inc.
0 catalysts
VOYXACT
VOYXACT (SIBEPRENLIMAB-SZSI)
Otsuka Pharmaceutical Co Ltd
0 catalysts
Phase 2
VP-001
Retinitis Pigmentosa (Retinitis)
PYC Therapeutics Ltd
0 catalysts
Preclinical
VPD-380
Pulmonary Arterial Hypertension
Corsair Pharma Inc
0 catalysts
Phase 2
VR-101
Female Contraception
VaRi Bioscience GmbH
0 catalysts
Phase 2
VR-103
Endometriosis
VaRi Bioscience GmbH
0 catalysts
VRAYLAR
VRAYLAR (CARIPRAZINE HYDROCHLORIDE)
1 . INDICATIONS AND USAGE VRAYLAR ® is indicated for: • Treatment of schizoph…
D(2) dopamine receptorD(3) dopamine receptor
$ABBVAbbVie Inc.
0 catalysts
Preclinical
VRG-145
Migraine
VRG Therapeutics Ltd
0 catalysts
Preclinical
VS-01
Hyperammonemia
Genfit SA
0 catalysts
Phase 1
VS-041
Diastolic Heart Failure (HFpEF)
Vasa Therapeutics SP Zoo
0 catalysts
Phase 1
VS-105
Secondary Hyperparathyroidism
Vidasym Inc
0 catalysts
Phase 2
VT-3989
Malignant Pleural Mesothelioma
Vivace Therapeutics Inc
0 catalysts
Phase 1
VT-A
Pulmonary Arterial Hypertension
VasThera Co Ltd
0 catalysts
Preclinical
VTA-100
Limb-Girdle Muscular Dystrophy
Vita Therapeutics Inc
0 catalysts
Preclinical
VTI-1002
Bullous Pemphigoid
viDA Therapeutics Inc
0 catalysts
Phase 1
VTP-1000
Celiac Disease
$BRNSBarinthus Biotherapeutics plc.
0 catalysts
Phase 2
VTR-297
Onychomycosis (Tinea Unguium)
$VNDAVanda Pharmaceuticals Inc.
0 catalysts
Preclinical
VTRU-200
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Vitruviae LLC
0 catalysts
Preclinical
VTX-803
Progressive Familial Intrahepatic Cholestasis
Vivet Therapeutics SAS
0 catalysts
Preclinical
VTX-806
Cerebrotendinous Xanthomatosis
Vivet Therapeutics SAS
0 catalysts
Phase 2
VTx-002
Amyotrophic Lateral Sclerosis
VectorY Therapeutics Inc
0 catalysts
VUSION
VUSION (MICONAZOLE NITRATE, ZINC OXIDE, WHITE PETROLATUM)
MYLAN
0 catalysts
Preclinical
VV-169
Refractory Multiple Myeloma
$NVSNOVARTIS AG
0 catalysts
Preclinical
VV-2003
Enterocolitis
Vivreon Biosciences LLC
0 catalysts
Preclinical
VV-8325
Alzheimer's Disease
Vivreon Biosciences LLC
0 catalysts
Phase 1
VVD-037
Solid Tumor
Vividion Therapeutics Inc
0 catalysts
Phase 1
VVD-850
Non-Small Cell Lung Cancer
Vividion Therapeutics Inc
0 catalysts